Stability and activity in sputum of G10KHc, a potent anti-pseudomonas antimicrobial peptide

Randal Eckert, Ian Howard Mchardy, Daniel K. Yarbrough, Jian He, Fengxia Qi, Maxwell H. Anderson, Wenyuan Shi

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

G10KHc, a specifically targeted antimicrobial peptide developed in our laboratory, has shown rapid and selective killing activity against Pseudomonas aeruginosa in culture medium. Because of the major role played by this pathogen in cystic fibrosis, we sought to evaluate the utility of G10KHc under more physiologic conditions in vitro. In the current study, we found that robust G10KHc activity could be maintained in expectorated sputum if serine protease-dependant digestion associated with this fluid was inhibited, either by chemical antagonists or by the construction of a d-amino acid enantiomer of G10KHc. Further investigations revealed that specifically targeted antimicrobial peptide activity in sputum could be further enhanced when samples were treated with a combination of peptide and recombinant human DNase. Our results illustrate the importance of investigating combination therapy to treat cystic fibrosis, especially if protease-sensitive peptide-based agents, such as G10KHc, are to be developed as alternatives to, or in conjunction with, conventional small-molecule antibiotics.

Original languageEnglish (US)
Pages (from-to)456-460
Number of pages5
JournalChemical Biology and Drug Design
Volume70
Issue number5
DOIs
StatePublished - Nov 2007

Fingerprint

Pseudomonas
Sputum
Peptides
Cystic Fibrosis
Enantiomers
Serine Proteases
Pathogens
Pseudomonas aeruginosa
Culture Media
Digestion
Peptide Hydrolases
Anti-Bacterial Agents
Amino Acids
Molecules
Fluids
Therapeutics

Keywords

  • Antimicrobial peptide
  • Cystic fibrosis
  • D-amino acids
  • Pseudomonas
  • Targeted therapeutic

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Medicine

Cite this

Stability and activity in sputum of G10KHc, a potent anti-pseudomonas antimicrobial peptide. / Eckert, Randal; Mchardy, Ian Howard; Yarbrough, Daniel K.; He, Jian; Qi, Fengxia; Anderson, Maxwell H.; Shi, Wenyuan.

In: Chemical Biology and Drug Design, Vol. 70, No. 5, 11.2007, p. 456-460.

Research output: Contribution to journalArticle

Eckert, Randal ; Mchardy, Ian Howard ; Yarbrough, Daniel K. ; He, Jian ; Qi, Fengxia ; Anderson, Maxwell H. ; Shi, Wenyuan. / Stability and activity in sputum of G10KHc, a potent anti-pseudomonas antimicrobial peptide. In: Chemical Biology and Drug Design. 2007 ; Vol. 70, No. 5. pp. 456-460.
@article{bb41d281a8b04646a0a54c9f058c4f6e,
title = "Stability and activity in sputum of G10KHc, a potent anti-pseudomonas antimicrobial peptide",
abstract = "G10KHc, a specifically targeted antimicrobial peptide developed in our laboratory, has shown rapid and selective killing activity against Pseudomonas aeruginosa in culture medium. Because of the major role played by this pathogen in cystic fibrosis, we sought to evaluate the utility of G10KHc under more physiologic conditions in vitro. In the current study, we found that robust G10KHc activity could be maintained in expectorated sputum if serine protease-dependant digestion associated with this fluid was inhibited, either by chemical antagonists or by the construction of a d-amino acid enantiomer of G10KHc. Further investigations revealed that specifically targeted antimicrobial peptide activity in sputum could be further enhanced when samples were treated with a combination of peptide and recombinant human DNase. Our results illustrate the importance of investigating combination therapy to treat cystic fibrosis, especially if protease-sensitive peptide-based agents, such as G10KHc, are to be developed as alternatives to, or in conjunction with, conventional small-molecule antibiotics.",
keywords = "Antimicrobial peptide, Cystic fibrosis, D-amino acids, Pseudomonas, Targeted therapeutic",
author = "Randal Eckert and Mchardy, {Ian Howard} and Yarbrough, {Daniel K.} and Jian He and Fengxia Qi and Anderson, {Maxwell H.} and Wenyuan Shi",
year = "2007",
month = "11",
doi = "10.1111/j.1747-0285.2007.00580.x",
language = "English (US)",
volume = "70",
pages = "456--460",
journal = "Chemical Biology and Drug Design",
issn = "1747-0277",
publisher = "Blackwell",
number = "5",

}

TY - JOUR

T1 - Stability and activity in sputum of G10KHc, a potent anti-pseudomonas antimicrobial peptide

AU - Eckert, Randal

AU - Mchardy, Ian Howard

AU - Yarbrough, Daniel K.

AU - He, Jian

AU - Qi, Fengxia

AU - Anderson, Maxwell H.

AU - Shi, Wenyuan

PY - 2007/11

Y1 - 2007/11

N2 - G10KHc, a specifically targeted antimicrobial peptide developed in our laboratory, has shown rapid and selective killing activity against Pseudomonas aeruginosa in culture medium. Because of the major role played by this pathogen in cystic fibrosis, we sought to evaluate the utility of G10KHc under more physiologic conditions in vitro. In the current study, we found that robust G10KHc activity could be maintained in expectorated sputum if serine protease-dependant digestion associated with this fluid was inhibited, either by chemical antagonists or by the construction of a d-amino acid enantiomer of G10KHc. Further investigations revealed that specifically targeted antimicrobial peptide activity in sputum could be further enhanced when samples were treated with a combination of peptide and recombinant human DNase. Our results illustrate the importance of investigating combination therapy to treat cystic fibrosis, especially if protease-sensitive peptide-based agents, such as G10KHc, are to be developed as alternatives to, or in conjunction with, conventional small-molecule antibiotics.

AB - G10KHc, a specifically targeted antimicrobial peptide developed in our laboratory, has shown rapid and selective killing activity against Pseudomonas aeruginosa in culture medium. Because of the major role played by this pathogen in cystic fibrosis, we sought to evaluate the utility of G10KHc under more physiologic conditions in vitro. In the current study, we found that robust G10KHc activity could be maintained in expectorated sputum if serine protease-dependant digestion associated with this fluid was inhibited, either by chemical antagonists or by the construction of a d-amino acid enantiomer of G10KHc. Further investigations revealed that specifically targeted antimicrobial peptide activity in sputum could be further enhanced when samples were treated with a combination of peptide and recombinant human DNase. Our results illustrate the importance of investigating combination therapy to treat cystic fibrosis, especially if protease-sensitive peptide-based agents, such as G10KHc, are to be developed as alternatives to, or in conjunction with, conventional small-molecule antibiotics.

KW - Antimicrobial peptide

KW - Cystic fibrosis

KW - D-amino acids

KW - Pseudomonas

KW - Targeted therapeutic

UR - http://www.scopus.com/inward/record.url?scp=35348994316&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=35348994316&partnerID=8YFLogxK

U2 - 10.1111/j.1747-0285.2007.00580.x

DO - 10.1111/j.1747-0285.2007.00580.x

M3 - Article

VL - 70

SP - 456

EP - 460

JO - Chemical Biology and Drug Design

JF - Chemical Biology and Drug Design

SN - 1747-0277

IS - 5

ER -